[HTML][HTML] Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England …
Background The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
[HTML][HTML] Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England …
M Shrotri, M Krutikov, T Palmer, R Giddings… - The Lancet Infectious …, 2021 - covid19.sld.cu
Background The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI …
M Shrotri, M Krutikov, T Palmer… - The Lancet …, 2021 - discovery.ucl.ac.uk
BACKGROUND: The effectiveness of SARS-CoV-2 vaccines in older adults living in long-
term care facilities is uncertain. We investigated the protective effect of the first dose of the …
term care facilities is uncertain. We investigated the protective effect of the first dose of the …
Vaccine Effectiveness of the First Dose of ChAdox1 nCOV-19 and BNT162b2 Against SARS-CoV-2 Infection in Residents of Long Term Care Facilities (VIVALDI Study …
M Shrotri, M Krutikov, T Palmer, R Giddings, B Azmi… - papers.ssrn.com
Background: The effectiveness of SARS-CoV-2 vaccines in frail older adults living in Long-
Term Care Facilities (LTCFs) is uncertain. We estimated protective effects of the first dose of …
Term Care Facilities (LTCFs) is uncertain. We estimated protective effects of the first dose of …
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study)
M Shrotri, M Krutikov, T Palmer, R Giddings, B Azmi… - medRxiv, 2021 - medrxiv.org
Background The effectiveness of SARS-CoV-2 vaccines in frail older adults living in Long-
Term Care Facilities (LTCFs) is uncertain. We estimated protective effects of the first dose of …
Term Care Facilities (LTCFs) is uncertain. We estimated protective effects of the first dose of …
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI …
M Shrotri, M Krutikov, T Palmer, R Giddings, B Azmi… - 2021 - cabidigitallibrary.org
Background: The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI …
M Shrotri, M Krutikov, T Palmer, R Giddings… - The Lancet. Infectious …, 2021 - europepmc.org
Background The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
[PDF][PDF] Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England …
M Shrotri, M Krutikov, T Palmer, R Giddings, B Azmi… - facilities, 2021 - scholar.archive.org
Background The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
[引用][C] Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England …
M Shrotri, M Krutikov, T Palmer, R Giddings… - The Lancet Infectious …, 2021 - cir.nii.ac.jp
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2
infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort …
infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort …
[HTML][HTML] Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England …
M Shrotri, M Krutikov, T Palmer… - The Lancet …, 2021 - researchportal.ukhsa.gov.uk
Background: The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford …